A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 45/06 (2006.01) A61K 31/08 (2006.01) A61K 31/675 (2006.01) A61P 23/00 (2006.01)
Patent
CA 2697739
Provided herein are compositions, combinations, and methods comprising NMDA antagonists including, but not limited to, NMDA glutamate receptor antagonists such as [2-(8,9-dioxo-2,6- diazabicyclo[5.2.0]non-1-(7)-en-2-yl)alkyl]phosphonic acid and derivatives thereof, which are effective in reducing the amount of anesthetic required to maintain anesthesia (i.e. to achieve an anesthetic-sparing effect).
L'invention propose des compositions, des combinaisons et des procédés comportant des antagonistes de NMDA comprenant, mais sans s'y limiter, des antagonistes des récepteurs du glutamate NMDA tels que l'acide [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1-(7)-en-2-yl)alkyl]phosphonique et des dérivés de celui-ci, qui sont efficaces dans la réduction de la quantité d'anesthésique nécessaire pour maintenir l'anesthésie (à savoir, pour obtenir un effet d'épargne de l'anesthésique).
Cullen Thomas Gerard
Eppler Cecil Mark
Hustead David Robert
Muir William W. III
Zwijnenberg Raphael Johannes Gerhardus
Torys Llp
Wyeth Llc
LandOfFree
Compositions and methods employing nmda antagonists for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods employing nmda antagonists for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods employing nmda antagonists for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1870492